Wassim Assaad
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Wassim Assaad has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Bassem Yamout
Neurology Institute, Harley Street Medical Center, Abu Dhabi, United Arab Emirates
1 shared publication Hani Tamim
American University of Beirut Faculty of Medicine, Department of Biomedical Sciences, Beirut, Lebanon
1 shared publicationRiyad Goueider
University Tunis El Manar Faculty of Medicine, Laboratory of Research Neurodegenerative and Mental Diseases Tunis, Tunisia
1 shared publicationSaloua Mrabet
University Tunis El Manar Faculty of Medicine, Laboratory of Research Neurodegenerative and Mental Diseases Tunis, Tunisia
1 shared publication
Latest Publications
- Open Access
- 14 January 2020
- Published by SAGE Publications in Multiple Sclerosis Journal – Experimental, Translational and Clinical
- Vol. 6 (1)
Epidemiology and phenotypes of multiple sclerosis in the Middle East North Africa (MENA) region
The Middle East North Africa (MENA) region falls in the low-to-moderate multiple sclerosis (MS) prevalence zone, with prevalence rates slightly lower than Southern Europe but much higher than sub-Saharan Africa. However, there is clearly a trend toward increased MS prevalence over the last few decades, consistent with the globally rising prevalence of the disease. We analyzed all data collected from the MENACTRIMS (Middle East North Africa Committee for Treatment and Research in Multiple Sclerosis) registry by the end of December 2018. A total of 6885 patients were eligible for the study. Overall, the clinical phenotype of MS in the MENA region was not different from the Western phenotype except for earlier age at onset and a more aggressive clinical course leading to earlier disability.
- 14 January 2020
- Published by SAGE Publications in Multiple Sclerosis Journal – Experimental, Translational and Clinical
- Vol. 6 (1)
Open AccessEpidemiology and phenotypes of multiple sclerosis in the Middle East North Africa (MENA) region
The Middle East North Africa (MENA) region falls in the low-to-moderate multiple sclerosis (MS) prevalence zone, with prevalence rates slightly lower than Southern Europe but much higher than sub-Saharan Africa. However, there is clearly a trend toward increased MS prevalence over the last few decades, consistent with the globally rising prevalence of the disease. We analyzed all data collected from the MENACTRIMS (Middle East North Africa Committee for Treatment and Research in Multiple Sclerosis) registry by the end of December 2018. A total of 6885 patients were eligible for the study. Overall, the clinical phenotype of MS in the MENA region was not different from the Western phenotype except for earlier age at onset and a more aggressive clinical course leading to earlier disability.